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Combination of bioanalytical approaches and quantitative proteomics 
for the elucidation of the toxicity mechanisms associated to TiO2 
nanoparticles exposure in human keratinocytes 




1. Introduction  
Titanium dioxide nanoparticles (TiO2-NPs) belong to a large group of metallic 
nanoparticles.  These nanoparticles have been increasingly used in a variety of consumer 
products, such as cosmetics and sunscreens, paints and surface coatings. Compared to 
macrosized particles (MPs > 100 nm), nanoparticles (< 100 nm) show specific properties, 
such as large surface area per unit mass, small size and high reactivity.  For these reasons, 
there is a potentially harmful risks to human health when nanoparticles are inhaled, 
ingested or in contact with the skin (Iavicoli et al. 2011; Shi et al. 2013). TiO2 is found in 
three crystalline phase (rutile, anatase and brookit) but only the first two crystal structure 
are used in industry. Several studies have shown different toxicological responses of cells 
depending on the crystal form in different cell lines (Saquib et al. 2012; Gerloff et al. 
2012; Wang et al. 2015; Uboldi et al. 2016; Jain et al. 2017), and in most cases, anatase 
phase exhibited the highest toxicity compared to the others. Among the described 
cytotoxic effects induced by TiO2-NPs in different cells lines, ROS generation, DNA 
damage (Saquib et al. 2012; Wang et al. 2015), apoptosis, cell cycle arrest (Wu et al. 
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2010; Kansara et al. 2015) and increased inflammatory response (Han et al. 2005), are 
the most common.   
In particular, the use of TiO2-NPs in sunscreens and cosmetics makes relevant the 
study of their potential toxicity and hazardous effects in human skin, since they are in 
close contact for long periods of time. Previous reports, have evaluated the cytotoxicity 
(Wright et al. 2017), genotoxicity (Jaeger et al. 2012) or metabolic effects (Tucci et al. 
2013; Ren et al. 2018) of TiO2-NPs in human keratinocytes. However, a further 
evaluation to gain a deeper insight into the biomolecular mechanisms related to those 
observed effects have not yet been accomplished.  
Among the different existing alternatives in quantitative proteomics, stable 
isotopic labeling by amino acids in cell culture (SILAC), remains one of the most widely 
used approaches. In SILAC, cell populations are differentially labeled with either 12C6-
Lys/Arg (light culture) or 13C6-Lys/Arg (heavy culture). After complete labeling, the two 
cell cultures subjected to different conditions (e.g. control vs. exposure) are mixed in a 
1:1 ratio and processed (protein purification, separation, digestion, etc.) as one sample. 
This procedure allows for the quantification of differentially expressed proteins with high 
accuracy, thus allowing for the identification of altered or deregulated proteins 
(overexpressed or inhibited) between the two studied cellular conditions (Luque-Garcia 
et al. 2013). 
Based on all of the above, in the present work, we first investigated the toxicity of 
TiO2-NPs in human keratinocytes (HaCaT cell line) using bioanalytical approaches to 
evaluate cell viability, cellular uptake, apoptosis, and changes in the cell cycle pattern and 
in key regulators involved in cell cycle progression. This study was followed by a 
quantitative proteomic experiment using SILAC, with the aim to move forward and to 
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identify specific proteins and pathways altered upon TiO2-NPs exposure, which are the 
ultimate responsible of the toxicity effects observed in exposed human keratinocytes. 
 
2. Materials and methods  
2.1.Materials 
Commercial anatase titanium dioxide nanoparticles (TiO2-NPs) with < 25 nm particles 
size, MTT reagent, dimethyl sulfoxide (DMSO), Hoechst 33258 reagent and tubulin 
primary antibody were purchased from Sigma Aldrich. Dulbecco´s modified Eagle´s 
medium (DMEM), fetal bovine serum (FBS), penicillin/streptomycin, 0.1% 
trypsin/EDTA solution and phosphatase saline buffer (PBS) were obtained from Thermo 
Fisher Scientific. Cell culture mediums, LM011 and LM014, for SILAC experiment were 
purchased from DC Biosciences. FITC-Annexin V/PI kit and p21 primary antibody were 
obtained from Invitrogen and Santa Cruz respectively. 
 
For the characterization of these NPs, two stock solutions of 200 and 1000 mg/L, were 
prepared in Milli-Q water and analyzed by transmission electron microscopy (JEOL 
2100). All reagents used to evaluate the localization of NPs in cells were supplied by the 
microscopy analysis center (CNME). All samples analyzed of flow cytometry assays 
were measured using a FACScan flow cytometer (Becton-Dickinson).  
 
For gene expression assays, TRIzol reagent, Quantitect reverse transcription kit, TaqMan 
gene expression assays and TaqMan Fast advance master mix were purchased from 
Invitrogen, Quiagen and Thermo Fisher Scientific respectively. Nanodrop One (Thermo 
Fisher Scientific) was used to quantify RNA and PikoReal Real-time PCR system 
(Thermo Scientific) was used to performed RT-PCR analysis. Liquid chromatography 
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tandem-mass spectrometry (LC-MS/MS) was carried out using a LTQ XL ion trap mass 
spectrometer (Thermo Scientific). 
2.2.Cell culture and treatment 
The human keratinocyte cell line (HaCaT, Human adult low Calcium High Temperature 
Keratinocytes) was maintained in Dulbecco´s modified Eagle´s medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin at 37 
ºC and 5% CO2. HaCaT cells were exposed to different concentrations of TiO2-NPs 
ranging from 1 to 100 mg/L and incubated for 72 h. Cells were rinsed in phosphatase 
saline buffer (PBS) containing a 0.02% EDTA and harvested using 0.1% trypsin/EDTA 
solution. For the metabolic labeling, cells were cultured in either “light” (12C6-Arg and 
12C6-Lys) or “heavy” (
13C6-Arg and 
13C6-Lys) DMEM medium supplemented with 10% 
dyalized FBS and 100 units/mL of penicillin/streptomycin. Cells were grown for at least 
eight doubling to allow full incorporation of labeled amino acids. 
 
2.3.Cell viability assay  
HaCaT cells were seeded on 96-well plates and exposed to 1, 10, 30 or 100 mg/L of TiO2-
NPs for 72 h. 20 μL of 3-(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl tetrazolium bromide 
(MTT, 5 mg/mL) were added to each well and incubated for 4 h. After this time, the MTT 
solution was removed and 100 μL of dimethyl sulfoxide (DMSO) were added to dissolve 
the insoluble purple formazan product. The plate was then centrifuge and the supernatant 
of each well was transferred to a new 96-well plate for the measurement of the absorbance 




2.4.Localization of TiO2-NPs in HaCaT cells 
Cells were exposed to TiO2-NPs (10 mg/L) and incubated at 37 ºC in 5% CO2 for 72 h. 
Afterwards, the control and TiO2-NPs exposed cells were harvested, rinsed with PBS and 
fixed with 5% glutaraldehyde and 4% p-formaldehyde in PBS for 4 h at 4 ºC. After this 
time, cells were washed twice with PBS and incubated in PBS at 4 ºC overnight. After 
incubation with 1% OsO4 in Milli-Q water for 1 h at room temperature, the samples were 
washed, dehydrated in a graded series of acetone and embedded in resine for 72 h at 67 
ºC. Ultrafine sections were cut with an ultramicrotome, deposited onto copper grids, 
stained with uranyl acetate and chrome citrate and analyzed by transmission electron 
microscopy (JEOL 1010). 
 
2.5.Flow cytometry assays 
Measurement of apoptosis in TiO2-NPs (10 mg/L) exposed cells after 72 h was 
determined using an FITC-Annexin V/PI kit (Invitrogen). Cells were harvested and 
washed with cold PBS. 1x106 cells were resuspended in 1 mL binding buffer solution at 
pH 7.4 containing 50 mM HEPES, 700 mM NaCl and 12.5 mM CaCl2. 100 µL of the cell 
suspension was stained with 5 µL of FITC-annexin V and 1 µL of 100 µg/mL propidium 
iodide. Cells were incubated for 15 min in the dark at room temperature, diluted in 400 
µL of binding buffer and immediately examined using a FACScan flow cytometer 
(Becton-Dickinson). To evaluate the cell cycle pattern of TiO2-NPs exposed cells, 1x10
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cells were resuspended in 250 µL of PBS and mixed with the same volume of a solution 
containing 60% ethanol and 30 µg/mL Hoechst 33258 reagent. Cells were then incubated 




2.6.Gene expression: RT-qPCR analysis 
The mRNA levels of cell cycle related genes (Table 1) were measured in TiO2-NPs 
exposed HaCaT cells (10 mg/L and 72 h). Total RNA was isolated using TRIzol reagent 
(Invitrogen) according to the manufacturer’s instructions. The quantity of extracted RNA 
was measured by the Nanodrop One (Thermo Fisher Scientific). Synthesis of cDNA with 
integrated removal of genomic DNA contamination was performed by Quantitect reverse 
transcription kit (Quiagen) using 1μg of RNA. RT-PCR analysis was carried out using 
TaqMan gene expression assays (Thermo Fisher Scientific) and TaqMan Fast advance 
master mix (Thermo Fisher Scientific) according to the manufacturer’s instructions. The 
references of TaqMan gene expression assays used are listed in Table 1. All reactions 
were performed in a final volume of 10 μL. The reaction protocol was 2 min at 50 ºC, 10 
min at 95 ºC for activating the polymerase and 40 cycles for 15 s at 95 ºC and 1 min at 60 
ºC. Relative expression of genes was normalized using GADPH as the endogenous 
control and gene expression in each sample was calculated as 2–ΔΔCt.  
 
2.7.Western Blotting 
HaCaT cells were lysed with total lysis buffer containing a proteases inhibitors cocktail. 
Protein concentration was determined using the Bradford assay. Proteins were separated 
by electrophoresis on a 12.5% SDS-polyacrylamide gel and transferred to a nitrocellulose 
membrane (BioRad). Membrane was blocked with 3% skim milk in PBS-T (0.05 % 
Tween-20) for 1 h at room temperature. After blocking, membrane was incubated with 
the primary antibodies diluted in blocking buffer: tubulin 1:500 (Sigma Aldrich) for 1 h 
at room temperature and p21 1:200 (Santa Cruz) overnight at 4 ºC. After three 10 min 
washes, the membrane was incubated with the corresponding secondary antibodies HRP-
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conjugated for 1 h. The inmunoblot was then visualized by enhanced chemiluminescence 
detection (GE Healthcare). 
 
2.8. SILAC experiment 
Two large-scale SILAC replicates (107 cells per condition) were performed. Complete 
incorporation of 13C6-Lys and 
13C6-Arg after eight cell divisions in isotopically heavy 
medium was verified by MS of a protein digest (data not shown). HaCaT cells labeled 
with “heavy” (direct SILAC) or “light” (reversed SILAC) amino acids were exposed to 
10 mg/L of TiO2-NPs for 72 h. Then, cells grown in “heavy” and “light” medium were 
harvested, counted and mixed in a 1:1 ratio before subsequent processing. Cells were 
lysed in buffer containing protease inhibitors (Roche) and the protein concentration was 
determined using the Bradford method. Proteins were then separated by SDS-PAGE on 
10% SDS-polyacrylamide gels. After electrophoresis, the proteins were visualized by 
Coomassie blue staining and the gel lane was cut horizontally into 22 sections. Excised 
gel bands were de-stained in 25 mM ammonium bicarbonate/50% acetonitrile, cut into 
small pieces, dehydrated with acetonitrile and dried. Gel pieces were incubated with 12.5 
ng/µL trypsin solution in 25 mM ammonium bicarbonate overnight at 37 ºC. Peptides 
were extracted using acetonitrile and 5% formic acid, dried by vacuum centrifugation and 
reconstituted in 12 µL of an aqueous solution containing 2% acetonitrile and 0.1% formic 
acid. 
The peptides mixtures from different fractions were analyzed using a nanoflow 
LC-MS/MS. Peptides were loaded onto a C18 trap column (0.3 x 10 mm, SGE) and then 
separated on a reverse-phase column (75 μm x 25 cm fused silica capillary C18 HPLC 
PepMap column, 3 μm , 100 A, Thermo) with a linear gradient of 5-95% acetonitrile in 
0.1% aqueous solution of formic acid. The gradient was delivered over 120 min by a nano 
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LC ultra 1D plus system (Eksigent) at a flow-rate of 200 nL/min, through the analytical 
column to a stainless nano-bore emitter (Proxeon). The peptides were scanned and 
fragmented with an LTQ XL linear ion trap mass spectrometer (Thermo Scientific) 
operated in data-depend ZoomScan and MS/MS switching mode using the three most 
intensive precursor ions detected in a survey scan from 400 to 1600 u (three scans). 
ZoomScan mass window was set to 12 Da enabling monitoring of the entire 12C/13C 
isotopic envelope of most doubly and triply charged peptides. Singly charged ions were 
excluded for MS/MS analysis. 
Generated .raw files were converted to .mgf files for MASCOT data search. A 
database containing the NCBInr Homo Sapiens sequences (113620 entries as of 
03/31/2018) was searched using the MASCOT protein identification software (v2.3 
MatrixScience). Search criteria included trypsin specificity with one missed cleavage 
allowed, and with methionine oxidation, 13C6-Arg and 
13C6-Lys as variable modifications. 
Minimum precursor and fragment-ion mass accuracies for 1.2 and 0.3 Da were used. To 
consider a protein as an accurate identification, at least one bold (unique) red peptide (i.e. 
highest scoring peptide matching to protein with highest total score) was required, and at 
least two bold (unique) red peptides were required for quantification. Cut-off values for 
MASCOT scores of peptides and proteins were set to 40 (p<0.05) and 47 (p<0.01), 
respectively. The false positive rate was calculated by searching the same spectra against 
the NCBInr Homo Sapiens decoy database. Relative quantification ratios (RSILAC) of 
identified proteins based on peak area were calculated using Quixot (version 1.3.26) 
open-source software. Proteins ratios obtained by QuiXot were manually verified for all 
peptides. The biological processes related to the proteins found deregulated upon TiO2-
NPs exposure, were assigned based on the biological knowledge available in Gene 




3.1.Characterization and cytotoxicity of TiO2-NPs 
We used transmission electron microscopy to characterize the TiO2-NPs in terms of 
particle size, morphology and aggregation. TiO2-NPs presented spherical structure with 
a diameter around 20-30 nm and tendency to aggregate in suspension (Fig. 1A). 
We evaluated the effect of TiO2-NPs on the cell viability of HaCaT cells by means of the 
MTT assay, which measures the reducing potential of the cells. While healthy cells are 
able to reduce the MTT to formazan (a purple coloured compound), non-viable cells are 
unable to do so. Thus, cell viability can be estimated by measuring the absorbance of the 
MTT-treated cells. As expected, the viability of HaCaT cells exposed to TiO2-NPs for 72 
h, decreased with increasing concentrations of the NPs (Fig. 1B). In order to evaluate the 
potential toxicity of TiO2-NPs but without drastically compromising the cell viability, we 
chose 10 mg/L as the most suitable concentration for further experiments. 
 
3.2.Cellular uptake and localization of TiO2-NPs 
We used transmission electron microscopy (TEM) for investigating the internalization 
and localization of TiO2-NPs in exposed HaCaT cells (Fig. 2). Several TiO2-NPs 
aggregates were found in most of the exposed cells (Fig. 2B). These aggregates, where 
either found close to the cellular surface, where we observed invaginations of the plasma 
membrane (Fig. 2C), or in vacuoles throughout the cytoplasm (Fig. 2B and 2D). As 
expected, these TiO2-NPs were not able to penetrate the nuclear membrane (Fig. 2E). 
Statistical analysis of 40 cell images (20 control cells and 20 cells exposed to TiO2-NPs) 
showed a significant increased (more than 2-fold) in the number of vacuoles in exposed 
cells as compared to control ones (Fig. 2F). 
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3.3. Flow cytometry assays 
We carried out two flow cytometry assays in order to explain whether the observed 
decreased in cell viability after exposure to TiO2-NPs, can be attributed to an increase in 
cell death or to a cell cycle arrest. The data obtained in both assays are shown in Fig. 3. 
Our data demonstrated that cells exposed to TiO2-NPs did not show a significant higher 
degree of apoptosis or necrosis as compared to control cells (Fig. 3A). On the contrary, 
while evaluating the effects of TiO2-NPs on the cell cycle pattern of HaCaT cells by 
measuring the content of DNA; cells exposed to TiO2-NPs showed a higher percentage 
of S/G2-M cells as compared to control cells. Also, the cellular population in G0/G1 
phase after nanoparticles exposure, was significantly lower than in control cells (Fig. 3B). 
Thus, we can conclude that TiO2-NPs did not induce a significant degree of apoptosis in 
HaCaT cells but they did induce a significant cell cycle arrest in S-G2/M phase. 
 
3.4. Gene expression assays 
Based on the flow cytometry results and in order to corroborate the cell cycle arrest 
induced by TiO2-NPs in HaCaT cells, we evaluated the mRNA levels of several key genes 
involved in cell cycle regulation. Since an increase of cell population was found in the 
transition from S phase to G2-M phases, we evaluated the checkpoints and mechanisms 
involved in these phases (Fig. 4A). The mRNA levels measured by RT-qPCR in HaCaT 
cells exposed to TiO2-NPs are shown in Fig. 4B. As for the components of the G1/S 
checkpoint, we observed a reduction of CDK2 mRNA level but we did not measure 
significant changes in the expression of cyclin E1 (CCNE1). On the other hand, in S phase 
during the DNA synthesis, another complex formed by CDK2 and cyclin A1 (CCNA1), 
constitute the S/G2 checkpoint. In this case, we found a decrease in the levels of both 
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transcripts (CDK2 and CCNA1) in TiO2-NPS exposed cells when compared with control 
cells (Fig. 4B). In addition, also a transcript involved in the G2/M checkpoint (CCNB1) 
was found significantly inhibited in cells exposed to TiO2-NPs.  
Cell cycle arrest in response to DNA damage involves protein stabilization and 
consequent upregulation of p53 (Macleod et al. 1995), which induces transcription of 
cyclin-dependent kinase inhibitor p21 (Gartel et al. 2002). Thus, we also evaluated the 
mRNA levels of p53 and p21. As expected, our results showed a significant increase in 
the expression of p53 in HaCaT cells exposed to TiO2-NPs. However, we observed a 
significant decrease in the expression of p21 in exposed cells. This result was not expected 
since p21 plays an essential role in growth arrest after DNA damage (Dulic et al 1994).  
Although this result may appear contradictory, p21 has also been demonstrated to 
function as a negative regulator of p53 under certain conditions (Broude et al. 2007).  
 
 
3.5.Western blot assay 
We carried out an immunoblot in order to further validate the previous result obtained for 
p21 mRNA and to evaluate its expression at the protein level. We observed that cells 
exposed to TiO2-NPs also showed a partial inhibition of p21 at the protein level as 





3.6.Quantitative proteomics  
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We performed a SILAC experiment to evaluate the differential protein expression after 
TiO2-NPs exposure (Fig. 5A).  A total of 1874 proteins were identified by mass 
spectrometry analysis with at least one unique peptide and a false discovery rate of 0.35% 
estimated from the number of hits against reverse or randomised sequence (decoy 
database)/total hits ratio at p > 0.01. However, only 538 proteins passed the selected 
criteria for quantitation (at least two unique peptides). We then studied the proteins with 
at least 1.5-fold expression difference between control and exposed cells (RSILAC over 
+1.5 or below -1.5) and with 20% as the maximum relative standard deviation for the 
RSILAC between peptides within each protein. According to these criteria, 66 proteins 
appeared deregulated in cells exposed to TiO2-NPs as compared to control ones. Out of 
these proteins, 30 were found upregulated (RSILAC > 1.5) (Table 2) and 36 were 
downregulated (RSILAC < 1.5) (Table 3). Regarding the SILAC ratio distribution, most of 
the identify proteins were within a RSILAC close to 1, as expected for a 1:1 mixture (Fig. 
5B). The 67 proteins found deregulated in HaCaT cells exposed to TiO2-NPs are involved 
in a variety of biological processes: cell cycle regulation, gene expression, metabolic 
processes and response to stimulus, among others (Fig. 5C). 
 
4. Discussion 
Several in vivo and in vitro studies carried out by different research groups have 
demonstrated that NPs-TiO2 can be absorbed by inhalation, ingestion and penetration 
through the skin (De Matteis V 2017).  Histopathological injuries have been observed 
mainly in lungs, kidneys, liver, spleen and nervous system among other components of 
the organism (Iavicoli et al 2011, Márquez-Ramírez et al 2012, Iavicoli et al 2012, Chen 
Z. et al. 2015, Valentini X et al. 2017 and 2018). The toxicological effects they generate 
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have been related to inflammatory responses that result in an increase in reactive oxygen 
species (ROS) (Saquib et al. 2012; Jaeger et al. 2012; Liu et al. 2010, Khana  et al. 2015). 
On the other hand, base modification, single or double DNA strand rupture and direct 
TiO2 bonds to repair enzymes or DNA can be observed in different models treated with 
high concentrations of these NPs (Saquib et al. 2012). Some metabolomic studies have 
identified numerous metabolites affected by the cytotoxicity of these NPs and involved 
in mitochondrial processes, redox homeostasis as well as inflammatory responses (Tucci 
et al. 2013). 
Our study have demonstrated the toxicity exerted by TiO2-NPs on human keratinocytes 
as well as the main biomolecular mechanisms involved in such toxicity. We first 
demonstrated that TiO2-NPs reduce the cell viability of HaCaT cells in a concentration-
dependent manner, in such way that exposure to 10 mg/mL for 72 h decreases the viability 
by a 40%, approximately. The reduction in viability is accompanied by the cellular uptake 
of TiO2-NPs, which form aggregates that localized mainly inside cytoplasmic vacuoles, 
as we have demonstrated by TEM. Thus, the degree of vacuolization in keratinocytes 
exposed to TiO2-NPs was significantly higher as compared to control cells. We further 
investigated whether the observed decrease in cellular viability was due to an induction 
of apoptosis or by a cell cycle arrest. Our flow cytometry experiments pointed out that, 
while TiO2-NPs did not significantly induce apoptosis, they induced cell cycle arrest at 
the S-G2/M phase. We validated these results by RT-qPCR and found inhibition of 
CDK2, CCNA1, CCNB1, which are key regulators of the G1/S, S/G2 and G2/M 
checkpoints, and whose inhibition induce cell cycle arrest, which is in agreement with the 
results obtained by flow cytometry.  
Since cell cycle arrest often involves protein stabilization and consequent 
upregulation of p53 (Macleod et al. 1995), which induces transcription of cyclin-
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dependent kinase inhibitor p21 (Gartel et al. 2002), we decided to also evaluated the 
mRNA levels of p53 and p21. While we found overexpression of p53 in keratinocytes 
exposed to TiO2-NPs, we did find inhibition of p21. This result was not expected since 
p21 plays an essential role in growth arrest after DNA damage (Dulic et al. 1994). In 
order to validate this result at the protein level, we carried out an immunoblot against p21, 
and the results also showed a significant inhibition of the protein. This result 
demonstrated that the inhibition of CDK2, CCNA1 and CCNB1, and thus, the observed 
cell cycle arrest upon TiO2-NPs exposure, is not mediated by overexpression of p21. On 
the other hand, despite the role of p21 as a negative regulator of the cell cycle, it is rarely 
inactivated in human cancer cells and often displays the expression pattern of an oncogene 
rather than the one of a tumor suppressor. This paradoxical pattern has been attributed to 
various activities of p21 other than CDK inhibition (Zhang et al. 1993). In fact, it has 
been described that p21 can act as a negative regulator of the cellular levels of p53 under 
certain circumstances (Broude et al. 2007), which seems to be the role observed in our 
experiment. 
To gain a deeper insight into the toxicity mechanisms associated to TiO2-NPs 
exposure in human keratinocytes, we decided to use a quantitative proteomic approach 
based on isotopic labeling (SILAC). We identified 66 deregulated proteins, which are 
involved in several biological processes including cell cycle regulation, gene expression, 
metabolic processes or response to stimulus, among others. One of the key steps in 
understanding the toxicity of a certain type of NPs, is elucidating the cellular 
internalization mechanism. Previous studies have described different pathways to explain 
the internalization process, which are mainly caveola-mediated, clathrin-mediated or 
other receptor-mediated endocytosis (Rauch et al. 2013). Caveola-mediated endocytosis 
or the “lipid-raft”-dependent process consists of the formation of invaginations in the cell 
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membrane, known as caveolae, where localizes lipids and some important proteins such 
as dinamin, which enables vesicle scission, cavin, which induces membrane curvature, 
and caveolin-1 (CAV-1), which is necessary for biogenesis of caveolae (Sahay et al. 
2010). Besides, CAV-1 is involved in vesicular transport during caveolae-mediated 
endocytosis and previous studies have demonstrated that this protein directly binds to 
Rab-5, which is involved in the transport between the early endosome and the caveosome, 
controlling its activity (Hagiwara et al. 2009). In our study, CAV-1 (RSILAC = 2.64) 
appears highly overexpressed, which might be related with the activation of the caveola-
endocytosis pathway upon TiO2-NPs exposure, and with the TiO2-NPs aggregates found 
in exposed HaCaT cells. This is in agreement with a similar study in which CAV-1, 
together with Cdc42, were demonstrated to be involved in the endocytosis of SiO2-NPs 
in HeLa cells (Bohmer et al. 2015). On the other hand, the clathrin-mediated endocytosis 
is based on the interaction of several proteins with clathrin, which is the main effector of 
the membrane coating to form vesicles.  Other proteins involved in this process are 
adaptor proteins such as AP2, epsins, dynamins and actin-binding proteins like CTTN 
(Cao et al. 2003; Samaj et al. 2003; Sauvonnet et al. 2005). CTTN participates in both 
clathrin-mediated endocytosis, where is needed as a component of clathrin-coated pits, 
and receptor-mediated endocytosis (Sauvonnet et al. 2005). Interestingly, we found 
CTTN (RSILAC = -1.67) to be inhibited in our experiment, which might preclude the 
internalization of TiO2-NPs by the clathrin- or receptor-mediated endocytosis. 
Additionally, PACSIN3 is a protein involved in vesicles formation and transport. In 
particular, it is related with the recruitment of proteins that play relevant roles in 
endocytosis processes. Previous reports have demonstrated that overexpression of 
PACSIN3 is a marker for the activation of the clathrin-mediated endocytosis route, 
leading to transferrin-mediated endocytosis arrest (Modregger et al. 2000). Based on the 
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previous results, it is not surprising that we found PACSIN3 inhibited (RSILAC = -1.85). 
This result, together with the downregulation of a key protein involved in the clathtin-
mediated route (CTTN) and the overexpression of CAV-1, support the idea that TiO2-
NPs internilize in human keratinocytes by caveola-mediated endocyotsis.  
Our previous experiments demonstrated that TiO2-NPs induce cell cycle arrest in 
exposed human keratinocytes, as it has been already pointed out by previous studies 
carried out in other types of cells (Saquib et al. 2012; Wang et al. 2015; Wu et al. 2010; 
Kansara et al.2015). Thus, we looked for altered proteins found in our SILAC experiment 
that could shed some light into the specific mechanisms responsible for the TiO2-NPs-
induced cell cycle arrest. Indeed, we found deregulation of several proteins involved in 
mitosis and cell cycle progression such as RanGAP1 (RSILAC = -2.09), NCAPG (RSILAC = 
-1.68), EIF4G2 (RSILAC = -2.51) and PPM1G (RSILAC = 2.90). Ran-binding protein-1 
(RanGAP1) stimulate the hydrolysis of GTP to GDP within the Ran GTPase cycle. This 
cycle include the control of both, the nucleocytoplasmic transport of important effectors 
in mitosis regulation, and the RanGTP and RanGDP balance levels. Levels of RanGTP 
inside the nucleus affect microtubules formation and their appropriate transformation to 
chromosomes during the interphase (Joseph et al. 2002; Clarke and Zhang 2008). In 
addition, RanGAP1 associates with mitotic spindles, which are particularly concentrated 
at foci near kinetochores; thus, several studies have demonstrated that deregulation of 
RanGAP1 triggers cell cycle arrest during M phase and deregulation of other proteins 
involved in cell cycle control (Swaminathan et al. 2004; Chang et al. 2013; Vorpahl et al. 
2014). NCAPG is the regulatory subunit of condensin complex, required for conversion 
of interphase chromatin into mitotic-like condense chromosomes (Kimura et al. 2001). It 
is well known that this protein is involved in the regulation of the cell cycle and previous 
report have shown that knocking down NCAPG provokes cell cycle arrest and impaired 
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cell proliferation. As for EIF4G2, also known as DAP-5, it is involved in the translation 
of important proteins during mitosis such as Cdk1 or Bcl-2. It has also been demonstrated 
that EIF4G2 is required for maintaining cell survival during mitosis, and that knocking 
down EIF4G2 induces M-phase specific caspase-dependent cell death (Marash 2008; 
Liberman et al. 2009). On the other hand, PPM1G, also known as PP2Cγ, is a 
serine/threonine phosphatase that regulates the transition phase of cell cycle. Unlike the 
other above mentioned proteins, we found PPM1G overexpressed in HaCaT cells exposed 
to TiO2-NPs. However, several reports have demonstrated that an overexpression of this 
protein provokes an accumulation of cells in the S phase (Suh et al. 2006), which is in 
agreement with our flow cytometry results, and with the reduction in mRNA levels found 
for CDK2 and cyclin A, which are both involved in the S/G2 checkpoint.  
TiO2-NPs are also considered to increase reactive oxygen species (ROS); thus, 
inducing oxidative stress and an imbalance in the normal redox state of cells (Saquib et 
al. 2012; Jaeger et al. 2012; Liu et al. 2010). Our SILAC experiment has allowed us to go 
further and to identify several proteins that might be responsible for the observed ROS 
increased and imbalance in TiO2-NPs exposed cells. Different enzymes with anti-oxidant 
properties are crucial for controlling the ROS balance. That is the case of SOD2, a 
mitochondrial protein involved in the conversion of O2- to H2O2, which was found was 
found inhibited (RSILAC = -2.71); thus confirming a potential imbalance of ROS in 
keratinocytes exposed to TiO2-NPs. This result is in agreement with the observations 
carried out by Li et al. in TiO2-NPs exposed nematodes (Li et al. 2012). Additionally, 
when cells undergo increased ROS levels and oxidative stress, there are certain proteins 
that act as a defense mechanism and whose overexpression may be used as an oxidative 
stress marker. That is the case of the peroxiredoxin protein family. In our SILAC 
experiment, we found upregulation of PRDX5 (RSILAC = 1.88), which reduces peroxides 
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with the use of reducing equivalents derived from thioredoxin. It has also been described 
that TiO2-NPs cellular uptake cause inflammatory responses (Han et al. 2013; Alinovi et 
al. 2015). Keratins are important effectors in the control of inflammatory network in 
keratinocytes; in particular, cytokeratin 1 (KRT1) plays a major role in the epidermal 
barrier formation and in restricting IL-18 release from keratinocytes. Previous reports 
showed that a knockdown of KRT1 cause a release of IL-18 and increase of inflammatory 
factors (Roth et al. 2012). Interestingly, we found downregulation of KRT1 (RSILAC = -
1.82) upon TiO2-NPs exposure, which might be one of the causes of the increased 
inflammatory response observed in TiO2-NPs exposed cells (Han et al. 2013; Alinovi et 
al. 2015).   
5. Conclusions 
In the present work, we have demonstrated the toxic effects exerted by TiO2-NPs in 
human keratinocytes. We have shown how the cellular viability of HaCaT cells is 
decreased in a concentration-dependent manner, and how TiO2-NPs induce cell cycle 
arrest at the S-G2/M phase. We have also supported this data by demonstrating inhibition 
of several key regulators involved in cell cycle progression such as CDK2, CCNA1 and 
CCNB1. Additionally, we have shown how TiO2-NPs induce downregulation of p21, 
which, in this case, seems to act as a negative regulator of p53 expression. Finally, using 
quantitative proteomics, we have identified several proteins involved in specific pathways 
and biological processes, that have helped us to understand the mechanisms underlying 
the observed toxic effects of TiO2-NPs on human keratinocytes. These findings, have 
allowed us to gain a deeper knowledge of the potential toxicity and the potential risk 
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Abbreviation list 
Arg: Arginine 
CDK: Cyclin-dependent kinase 
cDNA: complementary Deoxyribonucleic acid 
DMEM: Dulbecco´s modified Eagle´s medium 
DMSO: dimethyl sulfoxide 
DNA: Deoxyribonucleic acid  
EDTA: Ethylenediaminetetraacetic acid 
FBS: fetal bovine serum 
FITC-Annexin V: Fluorescein isothiocyanate (FITC)-labeled annexin V  
GADPH: glyceraldehyde-3-phosphate dehydrogenase 
HaCaT: Human adult low Calcium High Temperature Keratinocytes 
HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC: high performance liquid chromatography 
HRP: horseradish peroxidase 
LC-MS/MS: Liquid chromatography tandem-mass spectrometry 
Lys: Lysine 
MPs: macrosized particles 
mRNA: messenger Ribonucleic acid 
MTT: 3-(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl tetrazolium bromide 
NPs: nanoparticles 
PBS: phosphatase saline buffer 
PBS-T: phosphatase saline buffer with 0.05 % Tween-20 
PI: propidium iodide 
RNA: Ribonucleic acid 
ROS: reactive oxygen species 
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RT-qPCR:  Quantitative Reverse transcription polymerase chain reaction 
SDS: sodium dodecyl sulfate 
SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SILAC: stable isotopic labeling by amino acids in cell culture 
TEM: transmission electron microscopy 
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Table 1. Cell cycle related genes studied by RT-qPCR. 
Gene RefSeq Assay ID  
CDK1 NM_001170406.1 Hs00938777_m1  
CCNB1 NM_031966.3 Hs01030099_m1  
CDK2 NM_001290230.1 Hs01548894_m1  
CCNE1 NM_001238.3 Hs01026536_m1  
CCNA2 NM_001237.3 Hs00996788_m1  
CDKN1A NM_000389.4 Hs00355782_m1  
TP53 NM_000546.5 Hs01034249_m1  






















Protein Name RSILAC SILAC RSD 
SUPT16H 6005757 FACT complex subunit SPT16 5.70 9.62 
KRT10 195972866 keratin, type I cytoskeletal 10  3.51 11.33 
HNRNPUL2 118601081 heterogeneous nuclear ribonucleoprotein U-like protein 2  3.21 8.89 
PPM1G 29826282 protein phosphatase 1G  2.90 3.87 
CAV1 15451856 caveolin-1 isoform alpha 2.64 17.77 
CLPX 7242140 ATP-dependent Clp protease ATP-binding subunit clpX-like  2.28 18.23 
CA2 4557395 carbonic anhydrase 2  2.11 16.60 
VPS35 17999541 vacuolar protein sorting-associated protein 35  2.06 18.77 
EPRS 62241042 bifunctional glutamate/proline--tRNA ligase  2.05 12.84 
PRKCDBP 47132587 protein kinase C delta-binding protein  2.03 19.79 
HK1 188497754 hexokinase-1 isoform HKI  1.98 1.03 
SAMHD1 38016914 SAM domain and HD domain-containing protein 1 1.97 5.02 
VAMP3 4759300 vesicle-associated membrane protein 3 1.95 5.42 
PRDX5 6912238 peroxiredoxin-5, mitochondrial isoform a precursor  1.88 19.69 
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RPLP2 4506671 60S acidic ribosomal protein P2  1.82 3.33 
PSME3 388556516 proteasome activator complex subunit 3 isoform 3 1.79 18.56 
IPO7 5453998 importin-7  1.69 11.94 
FKBP4 4503729 peptidyl-prolyl cis-trans isomerase FKBP4  1.66 13.28 
CARS 62240992 cysteine--tRNA ligase, cytoplasmic isoform c  1.65 5.48 
RPLP0 4506667 60S acidic ribosomal protein P0  1.64 16.23 
PRKCSH 48255889 glucosidase 2 subunit beta isoform 1 precursor 1.63 15.77 
FASN 41872631 fatty acid synthase  1.61 11.17 
HKDC1 188497750 hexokinase-1 isoform HKI-td  1.59 4.13 
RPL29 4506629 60S ribosomal protein L29  1.57 18.28 
RUVBL2 5730023 ruvB-like 2  1.56 15.35 
SERPINB2 4505595 plasminogen activator inhibitor 2  1.55 18.71 
UCHL3 5174741 ubiquitin carboxyl-terminal hydrolase isozyme L3 isoform 2  1.52 6.98 
CCT4 38455427 T-complex protein 1 subunit delta isoform a  1.51 14.33 
PML1 67089149 protein PML isoform 1 1.51 16.55 













Protein Name RSILAC 
SILAC 
RSD 
DNAJB11 7706495 dnaJ homolog subfamily B member 11 precursor  -6.44 15.04 
SOD2 67782305 superoxide dismutase [Mn], mitochondrial isoform A precursor  -2.71 3.95 
EIF4G2 289577080 eukaryotic translation initiation factor 4 gamma 2 isoform 1  -2.51 13.36 
SLC9A3R1 4759140 Na(+)/H(+) exchange regulatory cofactor NHE-RF1  -2.19 14.75 
TUBB3 50592996 tubulin beta-3 chain isoform 1  -2.14 9.69 
RANGAP1 4506411 ran GTPase-activating protein 1  -2.09 8.14 
SERPINH1 32454741 serpin H1 precursor  -2.00 18.72 
SND1 77404397 staphylococcal nuclease domain-containing protein 1  -1.93 17.14 
PLS3 7549809 plastin-3 isoform 1  -1.93 19.02 
FAM129A 16757970 protein Niban isoform 2  -1.91 19.89 
PACSIN3 19224660 protein kinase C and casein kinase substrate in neurons protein 3  -1.85 1.64 
KRT1 119395750 keratin, type II cytoskeletal 1  -1.82 17.79 
ACAT1 4557237 acetyl-CoA acetyltransferase, mitochondrial precursor -1.79 19.94 
GLUD1 4885281 glutamate dehydrogenase 1, mitochondrial precursor  -1.78 17.49 
EEF1G 4503481 elongation factor 1-gamma  -1.77 10.75 
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IPO4 62460637 importin-4  -1.73 7.07 
MYBBP1A 157694492 myb-binding protein 1A isoform 2  -1.72 14.09 
EPS8L2 21264616 epidermal growth factor receptor kinase substrate 8-like protein 2  -1.70 4.13 
ATP5L 51479156 ATP synthase subunit g, mitochondrial  -1.69 10.34 
NCAPG 21359945 condensin complex subunit 3  -1.68 4.50 
LTA4H 4505029 leukotriene A-4 hydrolase isoform 1  -1.68 11.15 
HNRNPU 14141161 heterogeneous nuclear ribonucleoprotein U isoform b  -1.67 3.14 
CTTN 20357552 src substrate cortactin isoform a  -1.67 18.96 
PLEC 41322916 plectin isoform 1  -1.66 17.96 
SLC1A5 5032093 neutral amino acid transporter B(0) isoform 1  -1.66 18.63 
TOMM34 21361356 mitochondrial import receptor subunit TOM34  -1.65 14.47 
KRT7 67782365 keratin, type II cytoskeletal 7  -1.65 19.82 
CTSD 4503143 cathepsin D preproprotein  -1.63 19.08 
RPL21 18104948 60S ribosomal protein L21  -1.62 9.38 
HADHB 4504327 trifunctional enzyme subunit beta, mitochondrial precursor  -1.62 19.15 
RPN1 4506675 dolichyl-diphosphooligosaccharide--protein glycosyltransferase  -1.62 16.04 
FDPS 4503685 farnesyl pyrophosphate synthase isoform a  -1.61 17.34 
ARCN1 11863154 coatomer subunit delta isoform 1 -1.60 14.12 
ACTN1 194097350 alpha-actinin-1 isoform a  -1.57 17.69 
PTRF 42734430 polymerase I and transcript release factor -1.54 18.26 





Fig. 1. Morphologic characterization of TiO2-NPs by TEM and effects of these 
nanoparticles on HaCaT cell viability after 72h of exposure. (A) NPs show spherical 
shape and tendency to aggregate. (B) The reduction of cell viability after TiO2-NPs 
exposure was evaluated at different concentration (1, 10, 30, 100 µg/mL) by the MTT 
assay. 
 
Fig. 2. Transmission electron microscopy of HaCaT cells after TiO2 -NPs exposure.  
(B) NPs were found inside exposed HaCaT cells as aggregates when compared to (A) 
control cells. (C) Invaginations of the cell membrane were found in cells exposed to TiO2 
–NPs, (D) which were located in vacuoles inside the cells. (E) These NPs were not able 
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to penetrate the nuclear membrane. (F) Treated cells showed higher number of vacuoles 
as compared to control cells. **p < 0.01. 
 
Fig. 3. Flow cytometry assays to evaluate apoptosis and cell cycle pattern in HaCaT 
cells exposed to TiO2 -NPs. (A) Annexin-V-based flow cytometry analysis did not reveal 
a significant increase in apoptosis after the exposure. (B) Measurement of the DNA 
content by flow cytometry shows that the number of cells in S/G2-M significantly 
increase in TiO2-NPs exposed cells as compared to control ones. ***p<0.001. 
 
Fig. 4.  Gene expression and western blot analysis to evaluate the effects of TiO2 -
NPs exposure in the cell cycle pattern. (A) General scheme showing the essential role 
of Cdks and cyclins in cell cycle progression. (B) mRNA levels of several related-cell 
cycle genes in control cells and TiO2-NPs exposed cells. (C) Western blow analysis 
against p21; -tubulin was used as loading control. *p<0.05, **p<0.01 and ***p<0.001. 
 
Fig. 5. SILAC results. (A) General scheme of the SILAC experiment procedure. (B) 
Distribution of the SILAC ratios for the quantified proteins. Most quantified proteins 
presented a SILAC ratio close to 1 as expected for a 1:1 mixture. (C) Functional 
annotation of the 66 altered proteins upon TiO2-NPs exposure obtained from the gene 
ontology GO consortium website. Major molecular and biological processes altered 
included metabolic processes (MP), response to stimulus (RTS), transport (T), gene 
expression (GE), signalling (S), apoptosis (A), cell cycle regulation (CCR), protein 
folding (PF), DNA metabolic processes (DMP), response to stress (RTST) and cell 
proliferation (CP). 
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